| |
Total sample |
ADHD group |
Non-ADHD group |
p |
df |
t |
| Mean |
SD |
Mean |
SD |
Mean |
SD |
| HIV duration (months) |
8.9 |
3.9 |
7.55 |
±3.59 |
9.39 |
±3.25 |
0.0297* |
95 |
2.2077 |
| CD 4 counts |
342.6 |
196.4 |
399.1 |
±270.92 |
329.2 |
±175.61 |
0.160 |
98 |
1.4139 |
| |
n |
% |
n |
% |
n |
% |
|
|
χ2 |
| Individuals on HAART |
94 |
94% |
17 |
85% |
77 |
96.25% |
0.0171* |
1 |
1.873 |
| Good Adherence |
82 |
87.2% |
11 |
64.7% |
70 |
90.9% |
0.014* |
1 |
5.975 |
Note: SD=standard deviation, p=probability value for the t-test or chi-square test,
df=degrees of freedom, t=t value for the two tailed t-test, χ2= chi square value for
chi-square test. * indicates statistical significance at p<0.05. Good adherence was
defined as a minimum of 95% intake of prescribed HAART therapy. |
